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Abstract
Although fear of cancer recurrence is a great concern among survivors and their families, few
studies have examined predictors of fear of recurrence. The purpose of this study was to identify
factors associated with fear of recurrence in a population-based sample (N ¼ 246) and
determine if survivors and family caregivers influenced one another’s fear of recurrence. A
family framework guided the study and analyses included multilevel modeling using the
Actor-Partner Interdependence Model. Results indicated that survivors and family caregivers
influenced each other’s fear of recurrence and that caregivers had significantly more fear of
recurrence than survivors. More family stressors, less positive meaning of the illness, and age
were related to elevated fear of cancer recurrence for both survivors and caregivers.
Copyright # 2006 John Wiley & Sons, Ltd.
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Introduction
A large and growing cohort of cancer survivors has
generated new interest in the concerns they
experience after successfully completing treatment.
Currently there are over nine million cancer
survivors in the United States [1]. One of the major
concerns cancer survivors report is the fear that the
cancer will return [2--4]. This fear also extends to
the family members of cancer survivors [5,6]. Fear
of recurrence is rapidly becoming a universal
concern during survivorship, and has been linked
to poorer psychological adjustment, increased
emotional distress and lower quality of life out-
comes for survivors [7,8] and their family members
[6,9]. However, information is lacking on factors
that enhance or diminish fear of recurrence and on
how survivors and family members influence one
another’s fear. Further research on fear of recur-
rence is essential in order to help survivors and
family members find ways to manage this pervasive
fear and maintain their quality of life.
Using a family stress-coping framework, the
purpose of this study was to: (1) identify factors
associated with fear of recurrence in a population-
based sample of cancer survivors and their family
members, (2) determine the extent to which
survivors and family members influenced one
another’s fear of recurrence, and (3) assess
differences in predictors of fear of recurrence
between survivors and family caregivers.
Background
Studies on fear of recurrence
In spite of the numerous anecdotal reports of fear
of recurrence among cancer survivors, there have
been few systematic studies of this phenomenon.
The few studies that have been conducted indicate
that it is a commonly reported fear among cancer
survivors that persists over time [10--12]. Stanton
and colleagues [7] found moderate levels of fear of
recurrence in breast cancer survivors and no
change in their fear from 3 to 12 months post-
diagnosis. Other investigators have reported per-
sistent fear of recurrence in long-term cancer
survivors even though they were no longer in the
acute phase of illness [4,11,12].
Surprisingly, investigators have found that
family members have more fear of recurrence or
worry than do survivors themselves [3,13--15].
Some investigators contend that survivors may be
more preoccupied with the day-to-day aspects of
the illness, which distracts them from long-range
concerns about the illness [13]. Although the
specific explanation for family members’ greater
fear warrants further study, it is clear that fear of
recurrence is a persistent fear of both survivors and
their family members.
Even though fear of recurrence appears to be
universal, some survivors report more fear than
others. Vickberg [8] found that about half of the
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women with breast cancer in her study had
moderate to strong fear, while the remaining half
of the sample had very little fear. Mathews et al.
[16] reported that there was a subset of the
survivors in their study (31%) who had very high
worry about recurrence (i.e. two standard devia-
tions above the mean reported by the matched
controls), while other survivors had less fear. These
studies suggest that some survivors may be at
greater risk of higher fear of recurrence than
others.
Although fear of recurrence is fairly common-
place among survivors and their family members, it
is related to a number of negative outcomes.
Higher fear of recurrence is associated with
significantly higher emotional distress [7,8], more
intrusive thinking [8], lower vigor [7], lower well-
being in cancer survivors [8] and lower quality of
life among family members [9,17]. In addition,
survivors in one study who reported a high degree
of worry said that it negatively affected their daily
routine and interpersonal relationships [15]. Given
the detrimental effects that fear of recurrence can
have on survivors and their family members,
further research needs to identify factors associated
with fear of recurrence so that interventions can be
developed to lessen this fear.
Factors associated with fear of recurrence
A family stress-coping framework, adapted from
McCubbin and McCubbin’s resiliency model [18],
was used to guide this study and the selection of
factors that may be associated with fear of
recurrence. This model was adapted to examine
possible predictors of fear of recurrence for both
survivors and family caregivers. According to the
framework shown in Figure 1, the family’s ability
to adapt depends on personal factors (i.e. demo-
graphics), the number of stressors families face
(concurrent family stressors and illness-related
stressors), the family’s resources (family hardiness
and social support), and the family’s appraisal of
their situation (meaning of the cancer illness). The
model also suggests that a reciprocal relationship
exists between the level of fear reported by
survivors and their family members; each partner
affects the other (see Figure 1).
Among personal factors shown in Figure 1,
younger age has been associated with more
stressful appraisals of cancer [19] and more
fear of recurrence [5,7,8,20,21]. Few studies
have examined education, but Gil et al. [22]
reported that more educated women had more
triggers about recurrence than less educated
women. In regard to gender, female survivors
have reported more fear of recurrence than
male survivors [13] and female caregivers more
fear than male caregivers [3]. Although few studies
have examined race, African-American survivors
(mean 10 years post-diagnosis) have reported less
stressful appraisals of the cancer than Caucasian
survivors [19] and fewer triggers of fear of
recurrence [22].
According to the model, various stressors may
directly or indirectly affect fear of recurrence (see
Figure 1). Cancer survivors and their family
members who report more concurrent family
stressors also report more negative appraisals of
the cancer, more emotional distress, and lower
quality of life [23,24]. There are also a number of
illness-related stressors that may influence fear of
cancer recurrence. A shorter time since diagnosis
has been associated with more fear of recurrence in
some studies of cancer survivors [4] and their
family members [5], but not in other studies
[12,15,22]. Other health problems, experienced by
survivors or family members, may be related to
more fear of recurrence but this factor has not been
explored in prior research. Finally, survivors who
report more somatic concerns (e.g. fatigue), also
report more negative appraisals of the illness,
poorer adjustment to the illness [10,16,20,25,26],
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Figure 1. Family model of predictors of fear of recurrence
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Family resources also may affect appraisal
and fear of recurrence (see Figure 1). Northouse
et al. [24] found that family caregivers of
breast cancer patients who had more family
hardiness had less uncertainty, less hopelessness,
and better quality of life. Higher social support
has been associated with more positive mean-
ing derived from the cancer [27], less worry
[15], and less fear of recurrence among cancer
survivors [12].
According to the model, appraisal or the meaning
of the illness to cancer survivors and their family
members may mediate the relationship between the
antecedent factors and fear of recurrence (see
Figure 1). Several studies have found that the
more cancer survivors and family members ap-
praise the cancer experience as threatening, the
more it negatively affects their emotional adjust-
ment and quality of life [28,29].
Finally, the model specifies that an interrelation-
ship exists between the fear of recurrence of cancer
survivors and their family members (see Figure 1).
Several studies have documented the mutual
influence that patients and family members have
on each other’s adjustment and quality of life
[30--32]. These studies suggest that patients’ and
family members’ responses to cancer are interde-
pendent; each affects the other as indicated in
Figure 1. Further research is needed, however, to
determine the extent to which the fear of recurrence
is related in cancer survivors and family members
during long-term survivorship.
The specific research questions guiding this
study were: (a) What is the contribution of
personal factors (age, education, gender, and
race), stressors (concurrent family stressors and
illness-related stressors), family resources (family
hardiness and social support), and appraisal
(meaning of the illness) to fear of recurrence of
both the cancer survivor and family member? (b)
Does appraisal of the illness mediate the effect of
personal factors, stressors, and family resources on
fear of recurrence? (c) Is there an interrelationship
between the fear of recurrence of the cancer
survivor and the family member? And, (d) do these
relationships differ between cancer survivor and
family member?
Methods
This study was a secondary analysis of a large,
population-based study designed to examine
factors associated with quality of life in
cancer survivors and their family members [9,17].
Since fear of recurrence was an important pre-
dictor of family quality of life outcomes in the
parent study, this secondary analysis was con-
ducted to examine factors that contribute to
fear of recurrence.
Sample
A population-based sample was identified from the
Metropolitan Detroit Cancer Surveillance System
(MDCSS), a cancer registry and founding partici-
pant in the National Cancer Institute SEER
Program. The registry collects diagnostic, pathol-
ogy, and treatment data along with demographics
of all persons diagnosed with cancer occurring in a
3-county region of metropolitan Detroit. A sample
was randomly selected from the registry of patients
that was stratified by race (e.g. Caucasian and
African-American) and by cancer site (e.g. breast,
colon, prostate, uterine). Other eligibility criteria
specified that survivors were: 1--5 years post-
diagnosis, had a cancer stage of I--III, and were
50--70 years old at the time of diagnosis. These
criteria were chosen to target a survivor population
that was within a specified period of time post-
diagnosis, within an older age range to increase
sample homogeneity, and at an earlier stage of
illness to minimize likelihood of recurrence or
distant metastasis. Using these criteria, 373 cancer
survivors were identified from the SEER Registry.
There were additional eligibility criteria that
could not be determined from the SEER registry
but had to be assessed by contacting the potential
participant. These additional criteria included that
the survivors: had completed primary treatment at
least one year prior to participation, were not in a
recurrent or terminal stage of the illness, and had
an eligible family member willing to participate in
the study. ‘Family caregiver’ was broadly defined
as a family member or significant other who was
over 18 years of age. The survivor selected the
person who had been his/her primary source of
support during the cancer experience.
Of the 373 survivors contacted, 82 were unable
to be contacted (incorrect addresses or had moved
out of the area), 10 had died, and 74 individuals did
not meet the additional study criteria when
contacted by phone. Of the eligible survivors who
could be reached (N ¼ 207), 84 survivors declined
study participation. Reasons for declining in-
cluded: lack of interest, no time, other stressors,
anxiety about the cancer, and current involvement
in other research studies. The final sample who
participated in the study consisted of 123 dyads
(enrollment rate 60%). We compared those who
participated with non-participants on demographic
variables, and found only one significant differ-
ence. Study participants were significantly older
than non-participants.
Procedure
After obtaining institutional review board ap-
proval, the procedure for sample accrual followed
standard registry protocols. Registry staff sent
letters to the survivor’s physician to notify them
216 S. Mellon et al.
Copyright # 2006 John Wiley & Sons, Ltd. Psycho-Oncology 16: 214--223 (2007)
DOI: 10.1002/pon
of the study and to determine if survivors were
eligible to participate. The registry uses a passive
consent process; thus, if there was no response
from physicians within two weeks, registry staff
proceeded to contact the survivors to obtain their
permission to release their name to the research
team. Survivors willing to be contacted were sent a
letter that further described the study. After about
a week, a member of the research team made a
follow-up telephone call to survivors to determine
their interest in participation along with an eligible
family member.
All data collection sessions were approximately
one hour in length and took place in the survivor’s
home or another site selected by the family.
Master’s prepared nurses obtained the data from
both the survivor and family member during the
same visit, but each person completed the self-
report questionnaires alone. Written informed
consent was obtained for all participants prior to
their participation in the study. No additional
incentive was given to participants in the study.
Sample characteristics
The average age of the cancer survivor was 65 6.2
years (range, 52--75 years) and the average age of
the family caregiver was 55 14.5 years (range,
21--80 years). Since the sample was stratified on
race, slightly more than half (50.4%) of the family
dyads were Caucasian and half (49.6%) were
African-American. In this population-based sam-
ple, the mean years of education reported by
patients were 12.3 years and for family members
13.2 years. Family income ranged from 10.6% with
incomes less than $10 000 to 7.3% with incomes
over $90 000. The majority of families (65%) fell
between $11 000 and $60 000. The majority of
family caregivers participating were either spouses
(52.8%) or adult children (29.3%). Other relation-
ships represented in this sample were siblings
(8.1%) and significant others/extended family
members (9.7%). Additionally, a majority of the
survivors were married (64.2%).
Since the sample was stratified on diagnosis,
there were nearly equal groups of survivors in four
cancer diagnostic categories: 31 breast, 31 colon, 31
uterine, and 30 prostate cancer survivors. A variety
of treatment modalities were represented: surgery
(87.8%), radiation (39%), chemotherapy (22.8%),
and hormone therapy (3%). The majority of the
survivors (56.1%) had only one type of treatment
(surgery or radiation), while one-third of the
survivors had a combination of two treatments
(surgery/radiation; surgery/hormone; surgery/che-
motherapy; radiation/hormone). A small number
(n ¼ 11) of survivors had three types of treatment,
and four survivors had a total of four types. The
time since diagnosis for this sample of survivors
ranged from 1.5 to 6 years (M ¼ 3:4) and the time
since the primary treatment was completed was 1--6
years (M ¼ 3:0). Over 73% of the survivors and
50% of family caregivers also reported other health
problems, such as heart disease, arthritis, or
diabetes.
Measures
A researcher-designed questionnaire was used to
obtain personal information related to
participants’ age, education, gender, and race.
Additional information also was obtained on
family composition and the role relationship of
survivor to caregiver (i.e. spouse, sibling, adult
child).
Concurrent family stressors. An earlier version of
the Family Pressures Index [33] was used to
measure the other concurrent family stressors that
survivors and family members perceived as being
present for their families within the past year. This
version of the instrument was a 64-item scale with
an additional 8-item distress subscale that evolved
out of the Family Inventory of Life Events (FILE;
e.g. [34]. This adapted instrument measures the
stressors that families of today may experience (job
problems, effect of prejudice, concern for abuse of
alcohol/drugs, family conflict). A higher score
indicates more stressors for a family. Adequate
reliability and validity have been reported for the
Family Pressures Index [35]. The Cronbach’s alpha
reliability coefficient for survivors was 0.91 and
0.92 for family caregivers in this study.
Illness-related stressors were measured with an
investigator-developed instrument that identified
medical characteristics, including the primary
cancer site, time since diagnosis and completion
of primary treatment, and other non-cancer-related
health problems of both the survivor and family
caregiver. Information on survivors’ somatic con-
cerns was measured with the physical well-being
subscale of the Functional Assessment of Cancer
Therapy Scale (Fact G) [36]. This 7-item subscale
was used to capture any lingering symptoms or
physiological problems that survivors were still
experiencing. Evidence of adequate reliability and
validity of this widely used FACT instrument has
been reported previously [36]. This instrument was
completed only by the survivor, with an a
coefficient of 0.67.
Family hardiness. The 20-item Family Hardiness
Index (FHI; [37]) was used to measure family
hardiness, conceptualized as a family’s degree of
internal strengths and resiliency. The instrument
contains four subscales: co-oriented commitment,
confidence, challenge, and control. Only total scale
scores were used in the analyses for this study.
Evidence of reliability and validity has been
reported previously [37]. In this study, the alpha
reliability for the total score was 0.78 for survivors
and 0.80 for family caregivers.
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Social support. The Social Support Index (SSI;
[38]), a 17-item scale that measures the degree to
which families give support to its members, view
the community as a source of support, and feel that
the community context can provide emotional,
esteem, and network support. A 5-point Likert
scale was used, with higher scores indicating more
social support. Evidence of internal consistency,
test--retest reliability, and concurrent validity has
been reported [38]. The alpha reliability for social
support for survivors was 0.73 and 0.77 for family
caregivers.
Meaning of illness. The Constructed Meaning
Scale [27] was used to measure the meaning of
cancer to the family unit by both the survivor and
family member. The scale has a total of eight items
that include statements referencing the effects of
the illness on the individual’s identity, interperso-
nal relationships, and the future. The scale was
adapted for this study to measure the meaning of
cancer to the entire family unit, rather than only
individually. There are four possible responses for
each item, ranging from ‘strongly disagree’ (1) to
‘strongly agree’ (4). Higher scores indicate a more
positive meaning of the cancer experience, while a
lower score denotes a more negative or pessimistic
meaning. Psychometric properties of the original
scale have been reported with adequate reliability
and validity [27,39]. Reliability scores for the
adapted instrument in this study were 0.77 for
survivors and 0.78 for family caregivers.
Fear of recurrence. The Fear of Recurrence
Questionnaire [12] was used to measure the amount
of worry and concern that survivors and family
members have about the cancer returning in the
future. The 22-item instrument uses a Likert scale
format with both positively- and negatively worded
items. A modified version of the scale was
completed by family caregivers to report the
amount of concern they had regarding their family
member’s cancer recurring. Negatively worded
items were reverse-scored prior to creating the
summary score. A higher score on the scale
indicates a higher fear of recurrence. Psychometric
properties of the scale, including adequate content
validity and reliability, have been reported in prior
studies of breast cancer patients [12,21]. In the
present study, the reliability coefficients for survi-
vors were 0.92 and 0.91 for family caregivers.
Data analysis
To assess relationships among variables, Pearson
correlations (for continuous predictors) and point
biserial correlations (for categorical predictors)
were conducted for all study variables for survivors
and caregivers separately. Next, to assess the
proposed model for the effect of survivors and
family caregivers on one another, we conducted the
Actor--Partner Interdependence Model (APIM)
using multilevel modeling with PROC MIXED in
SAS 8.2 [40--44].
Multilevel modeling (or hierarchical linear mod-
eling) to estimate APIM treats the members of a
dyad as nested scores within the same group
[40,41]. This approach to estimate APIM has been
widely used by researchers (e.g. [45--48]) and has
several advantages over pooled regression and
structural equation modeling (SEM) approaches
[40]. The multilevel modeling approach is less
computationally complex, more flexible, and better
able to easily model and assess interactions than
pooled regression and SEM approaches to asses-
sing APIM [40]. A detailed description on how to
conduct APIM analyses using multilevel modeling
programs (e.g. HLM and SAS PROCMIXED) has
been previously outlined (see, [40]) and served as
the guide for our analysis plan.
The heart of the APIM approach is to assess
actor and partner effects. Actor effects refer to
whether a person’s score on a predictor variable
influences the person’s own outcome (i.e. either
survivor or family caregiver influences self). Part-
ner effects refer to whether a partner’s score on the
predictor variable influences another person’s out-
come (i.e. family caregiver influences survivor or
survivor influences family caregiver) [40,44].
In APIM there are three types of predictor
variables that can be used: within dyad variables,
between dyad variables, and mixed variables.
Within dyad variables differ between members of
the dyad but have the same value across dyads (e.g.
role of survivor vs family caregiver). Between dyad
variables are the same for members of the dyad but
differ across dyads (e.g. time since diagnosis).
Mixed variables occur when scores can differ both
within and between dyads (e.g. age, other health
problems, family stressors, family hardiness, social
support and family meaning). With APIM, actor
and partner effects are only assessed for mixed
variables. Main effects are assessed for within dyad
variables or between dyad variables.
Since the family model (see Figure 1) hypothe-
sizes that meaning of the illness mediates the
relationships between the predictors and fear of
recurrence, mediation was assessed using a mod-
ification of the approach outlined by Baron and
Kenny [49]. First, an APIM model assessed the
influence of the predictors on meaning. Second, an
APIM model assessed the influence of the pre-
dictors on fear of recurrence. Third, an APIM
model assessed the influence of the predictors plus
the mediator on fear of recurrence.
Finally, to assess whether any of the actor and
partner relationships differed between survivor and
family caregiver (i.e. whether there were different
predictors of fear of recurrence for survivors and
family caregivers), a set of interactions between
role and all predictor variables were entered one at
a time in the final model [50]. Any significant
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interactions were added to the final model. It is
important to understand potential differences in
factors that relate to fear of recurrence between
survivors and family caregivers in order to develop
effective family based interventions that reduce fear
for both survivors and caregivers.
In order to increase the interpretability of the
regression coefficients and because interaction
terms were modeled, all variables were centered
[51] using the mean from the combined data, which
is the recommended approach when centering
variables in the APIM model [40]. The actor and
partner effects presented in the model are unstan-
dardized regression coefficients (and their standard
errors).
Results
Table 1 shows the relationships between the
predictor variables and fear of recurrence for both
survivors and caregivers. Survivors and family
caregivers who reported more family stressors in
their lives and less meaning associated with the
illness had more fear of recurrence. Among
survivors only, those who reported other health
problems and more somatic symptoms also re-
ported higher fear of recurrence. Medical factors
such as type of cancer, stage of cancer, and type of
treatment received were not related to survivors’ or
family caregivers’ fear of recurrence.
Next, multilevel modeling was conducted using
APIM analysis to assess the model proposed in
Figure 1. First, an APIM model was assessed for
the set of predictors on meaning of the illness. Only
two variables had a significant actor effect on
perceived meaning of illness: family hardiness
(b ¼ 0:13; SE ¼ 0:04; t ¼ 3:77; p50:05) and social
support (b ¼ 0:10; SE ¼ 0:04; t ¼ 2:60; p50:05).
The more family hardiness and social support
individuals (both survivors and caregivers) per-
ceived, the more positive the meaning associated
with the illness. No significant partner effects were
found for meaning of the illness. Therefore, only
the actor effects for family hardiness and social
support could be further examined to determine if
their effects on fear of recurrence were mediated by
meaning of the illness [49].
To assess whether the relationships between
family hardiness and social support on fear of
recurrence were mediated by meaning, these two
variables had to demonstrate a direct relationship
with fear of recurrence without meaning in the
model. A multilevel model was conducted to assess
the influence of these predictors on fear of
recurrence. Results showed that neither family
hardiness nor social support related to fear of
recurrence (both p40:05). Therefore, the media-
tion proposed in Figure 1 was not supported.
To assess the influence of all of the predictors on
fear of recurrence, a final model was tested that
examined all variables simultaneously including
meaning. Results are depicted in Table 2. The
results showed significant actor effects for con-
current family stress and meaning. Individuals
(survivors and family caregivers) who reported
more family stress and less positive meaning had
more fear of recurrence. No other significant actor
effects were found. An individual’s (survivor and
caregiver) perceived level of family hardiness and
social support did not significantly influence the
individual’s fear of cancer recurrence.
To assess whether any actor effects differed
significantly between survivor and caregivers,
differences of actor effects between survivor and
caregiver were tested. A marginally significant
meaning of illness by relationship role (survivor
vs caregiver) interaction effect was found
(p ¼ 0:06). Simple effects showed that even though
less meaning of illness significantly related to more
fear of recurrence for both survivors and care-
givers, the relationship was stronger for survivors
(b ¼ 1:34) than for caregivers (b ¼ 0:64).
In regard to partner effects in the APIM
analyses, results showed only one significant
partner effect and that was for age of partners.
When the age of the survivor decreased, the
caregiver’s fear increased. Similarly, when the age
of the caregiver decreased, the survivor’s fear
increased. No other significant partner effects were
found. Neither survivors’ nor family caregivers’
levels of stress, perceived hardiness, social support,
and perceived meaning had a significant influence
Table 1. Correlation of personal, social, illness, and appraisal










Concurrent family stressorsa 0.31** 0.29**
Time since diagnosisa 0.05 0.01
Other health problemsb 0.35** 0.02
Somatic concernsa 0.19* 0.15
Family resources
Family hardinessa 0.16 0.09
Social supporta 0.15 0.05
Appraisal
Meaning of cancer illnessa 0.43** 0.28**
**p50:01; *p50:05:
aPearson r correlation coefficient.
bPoint biserial correlations.
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on the fear of recurrence of the other member in
the dyad.
To assess whether any partner effects signifi-
cantly differed between survivor and caregivers,
differences of partner effects between survivor and
caregiver were tested. Results showed a significant
partner age by relationship role (survivor vs
caregiver) interaction (p50:05). This interaction
shows that dyads comprised of older survivors with
younger caregivers had more fear of recurrence
than other dyads.
Results also indicated that the relationship role,
a within dyad variable, influenced fear of recur-
rence. Family caregivers had significantly more fear
of recurrence than patients (even after controlling
for the other variables in the model). There were no
significant relationships between gender, race,
education, or time since diagnosis and fear of
recurrence.
The partial intraclass correlation for the final
model was 0.41, indicating that after controlling
for all the predictors, there was a significant and
fairly strong correlation between survivors and
family caregivers’ fear of recurrence. This suggests
that survivors and family caregivers mutually
influenced each others’ fear of recurrence. The
final model after the APIM testing is shown in
Figure 2.
Discussion
This study identified factors that had an indepen-
dent and interdependent influence on survivors’
and family caregivers’ fear of recurrence during
survivorship. Using APIM analyses, we found
more ‘actor effects’ than ‘partner effects’. In other
words, we found that each person’s own percep-
tions rather than their partners’ perception exerted
more influence on individuals’ levels of fear of
recurrence. Stressors and appraisal (i.e. meaning of
the illness to the family), accounted for the most
variance in both survivors’ and family caregivers’
fear of recurrence. In regard to stressors, survivors
and family caregivers who reported more concur-
rent family stressors had more fear of cancer
recurrence. This finding also is consistent with
reports from other studies that more concurrent
stress is associated with higher emotional distress
and lower quality of life among cancer survivors
Table 2. The influence of personal, social, illness and appraisal
factors on fear of recurrence
b SE t p
Personal factors
Age
Actor effect 0.11 0.24 0.46 0.69
Partner effect 0.52 0.24 2.12 0.04*
Education 1.01 1.12 0.90 0.33
Gender (patient) 0.99 2.55 0.39 0.70




Actor effect 0.34 0.10 3.37 0.001**
Partner effect 0.04 0.10 0.41 0.68
Time since diagnosis 0.43 1.18 0.37 0.72
Other health problems
Actor effect 4.75 2.46 1.95 0.054
Partner effect 3.27 2.46 1.34 0.18
Somatic concerns 1.75 1.16 1.50 0.14
Family resources
Family hardiness
Actor effect 0.16 0.21 0.76 0.45
Partner effect 0.24 0.21 1.19 0.24
Social support
Actor effect 0.12 0.21 0.55 0.59
Partner effect 0.21 0.21 0.96 0.34
Appraisal factor
Family meaning
Actor effect 1.24 0.39 3.19 0.002**
Partner effect 0.23 0.39 0.59 0.56
Relationship role




• Age (partner effect)
• Concurrent Family Stressors (Actor Effect)
• Meaning of Cancer Illness (Actor Effect)
Stressors
Appraisal
Fear of Recurrence 
Cancer Survivor






Figure 2. APIM Model of predictors after testing (model depicts only significant relationships with outcomes after testing)
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and their family members [23,24]. Concurrent
family stress may drain survivors’ and family
caregivers’ mental energy and use up coping
resources that would otherwise be available to
help them manage the threat of cancer recurrence.
We also found that other health problems were
related to more fear of recurrence in survivors.
These illness-related stressors may further exacer-
bate concerns about fear of recurrence for cancer
survivors.
Another ‘actor’ effect influencing fear of recur-
rence was meaning of the illness. Survivors and
family caregivers who reported more positive
meaning associated with the illness had signifi-
cantly less fear of recurrence. It was each indivi-
dual’s own meaning of the illness, rather than the
influence of their partner’s meaning, that affected
each individual’s own fear of recurrence. A number
of other investigators have also found a significant
relationship between finding meaning in a cancer
illness and positive health outcomes such as better
adjustment, less anxiety, less depression, and
improved role functioning [39,52]. This suggests
that individual appraisal, or the meaning of cancer,
may be an important factor for reducing risk
susceptibility to long-term distress in survivors and
their family members.
There was only one ‘partner’ effect in our study,
with findings suggesting that age has a differential
influence on fear of recurrence. In all dyads, when
the partner’s age decreased, both the survivor’s and
caregiver’s fear of the cancer returning increased.
Thus, survivors with younger caregivers and
caregivers with younger survivors both experienced
more fear. Survivors may worry about the well-
being of their younger caregiver who may be left
with greater family disruption and economic hard-
ship if the cancer returns. Similarly, caregivers with
younger survivors may worry about the potential
loss of their loved one earlier than expected in life.
There were also significant within dyad effects,
specifically in the role relationship in the family.
Family caregivers had significantly more fear of
recurrence than survivors. This finding is consistent
with other studies that report family members are
more distressed and worried about the future than
the cancer survivor themselves [3,13,31]. Ell and
colleagues [53] suggest that having less personal
control, less social support and greater stress
overall contributes to family members’ problems
adjusting to their loved one’s cancer. Perhaps
family caregivers who are standing by to provide
support to the survivor do not address their own
personal fears or are reluctant to burden the cancer
survivor with their own fears. Hence, family
caregivers may be less likely to work through or
resolve their own fear of the cancer returning. This
has important implications for long-term quality of
life and role functioning outcomes within families if
family caregivers’ fears are not addressed.
Another important finding from this study was
the interdependence between the survivors’ and
caregivers’ fear of recurrence. As one family
member’s fear increased, so did the other mem-
ber’s. The interrelationship between family mem-
bers’ responses to cancer has been reported in other
research [30--32, 54,55], and this study extends the
family’s mutual influence to the ongoing fear of
recurrence prevalent during the extended survivor-
ship period.
Overall, the proposed family-based theoretical
model received partial support as shown in Figure
2. Certain personal characteristics, stressors, and
meaning of the illness contributed to survivors’ and
family caregivers’ fear of recurrence. Although we
hypothesized that meaning of the illness would
mediate the relationship between the antecedent
factors (personal characteristics, stressors, and
family resources) and fear of recurrence, it did
not. Meaning had a direct effect on fear of
recurrence, but was not a mediator in this study.
Further, while age was found to be predictive of
fear of recurrence, other personal factors were not.
While some studies have detailed gender differ-
ences in survivorship and quality of life, only a few
have begun to address gender in fear of recurrence
[3,13]. Although we were expecting possible differ-
ences related to gender effects, with women having
more fear than men, this was not found in our
sample. A possible explanation is that age effects
were more dominant than gender effects in this
longer-term survivor population who were not in
active treatment. Further study is warranted to
determine if there is an interplay of age, gender,
and treatment effects during long-term survivor-
ship.
Other parts of the model, such as family
resources, (family hardiness and social support),
were also not related to fear of recurrence in this
study. This was somewhat surprising in light of the
positive relationships that have been reported
between support and adjustment in previous
studies [12,56]. However, in this study we chose
to use more generic, community-based measures of
family resources rather than cancer-specific mea-
sures because survivors were no longer in the acute
phase of illness. While these instruments captured
general support from family and the community,
they did not capture the support available to assist
survivors and family caregivers to deal with cancer-
specific worries and concerns. This may account for
the lack of relationship found between resources
and fear of recurrence in this study.
This study had several limitations. Although we
based our study on a theoretical model, several
other potential variables could have been included.
Other potential variables to consider include
optimism [57], self-efficacy [58], active vs avoidant
coping [7], family functioning [59] and family
communication [5]. A second limitation is the
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retrospective, cross-sectional design of the study.
The analysis and discussion of the findings imply
some directionality that needs to be viewed with
caution. Prospective, longitudinal studies are
needed in order to establish directionality and
causality among the associations found in this
study. Another limitation is the study used self-
report assessments of health and well-being. Future
studies may benefit from using both self-report and
biological assessments of stress and health. Finally,
some of the measures were adapted to be appro-
priate for family members (e.g. meaning of illness),
which may have influenced some of the statistical
relationships. However, it should be noted that
these adapted scales still demonstrated adequate
psychometric characteristics.
Conclusion
Overall, the results of this study indicate that both
individual and dyadic factors are associated with the
amount of fear of recurrence reported by long-term
cancer survivors and their family caregivers. These
findings underscore the importance of factoring in
dyadic and family effects when studying cancer
survivorship. Among individual factors, each
person’s own perception of the stressors within
the family and the meaning they associate with the
illness accounted for a significant amount of
variance in their fear of recurrence. Among dyadic
factors, the level of fear of recurrence experienced
by one partner influenced the amount of fear
experienced by the other. Furthermore, the young-
er age of one member of the dyad was associated
with greater fear in the older member of the dyad.
In view of the fact that fear of recurrence has been
linked with the important outcomes of quality of
life, distress, and psychosocial adjustment, it is
critical to address potential factors that may
influence both survivors’ and family caregivers’
fear of recurrence during long-term cancer survi-
vorship.
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